Search results for "live birth"

showing 10 items of 57 documents

Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation …

2020

<b><i>Purpose:</i></b> To assess whether open and closed vitrification protocols are equally effective for sibling-oocyte cycles when performing blastocyst embryo transfers. <b><i>Materials and Methods:</i></b> A prospective study was set up comparing the open and the closed vitrification techniques in oocyte recipients sharing sibling oocytes between 2014 and 2016. Sibling oocytes were randomly and equally assigned into the closed group (oocytes vitrified in a closed system) or the open group (oocytes vitrified in an open system). Intracytoplasmic sperm injection was performed on all cases. Embryo transfers were performed on day 5. Power anal…

AdultPregnancy Ratemedicine.medical_treatmentIntracytoplasmic sperm injectionAndrology03 medical and health sciences0302 clinical medicineHuman fertilizationPregnancymedicineHumansVitrificationBlastocystAdult Birth RateEmbryo ImplantationProspective StudiesSperm Injections IntracytoplasmicBirth RateSurvival rateCryopreservation030219 obstetrics & reproductive medicineOocyte Donationbusiness.industryObstetrics and GynecologyEmbryoOocyteEmbryo TransferVitrificationInfertility; Oocyte donation; Vitrificationmedicine.anatomical_structureBlastocystReproductive Medicine030220 oncology & carcinogenesisInfertilityOocytesFemaleLive birthbusinessGynecologic and obstetric investigation
researchProduct

One uterus bridging three generations: first live birth after mother-to-daughter uterus transplantation

2016

Objective To determine whether a uterus from the mother of a woman with absolute uterine factor infertility can be transplanted to daughter and carry a pregnancy with delivery of a healthy child. Design Part of an observational study. Setting University teaching hospital. Patient(s) Twenty eight-year-old woman with uterine agenesis, her male partner, and her 50-year-old mother. Intervention(s) In vitro fertilization with embryo cryopreservation before live donor uterus transplantation (UTx). Induction immunosuppression. Embryo transfer 12 months after UTx, pregnancy controls, delivery, and hysterectomy. Main Outcome Measure(s) Results of IVF-ET, parameters of pregnancy/birth, and surgical d…

Adultmedicine.medical_specialty46 XX Disorders of Sex Developmentmedicine.medical_treatmentMothersFertilization in VitroHysterectomyCongenital AbnormalitiesUterine AgenesisHospitals University03 medical and health sciences0302 clinical medicinePregnancyUterus transplantationLiving DonorsmedicineHumansMullerian DuctsCryopreservationImmunosuppression TherapySwedenGynecologyPregnancy030219 obstetrics & reproductive medicineHysterectomyCesarean SectionObstetricsbusiness.industryUterusObstetrics and GynecologyMiddle AgedEmbryo Transfermedicine.diseaseEmbryo transferTransplantationFertilityTreatment OutcomeReproductive Medicine030220 oncology & carcinogenesisAdult ChildrenGestationFemalebusinessLive birthInfertility FemaleLive BirthFertility and Sterility
researchProduct

The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.

2014

STUDY QUESTION: Does the combined oral contraceptive pill (COCP) change endometrial gene expression when used for cycle programming? SUMMARY ANSWER: COCP used for scheduling purposes does not have a significant impact on endometrial gene expression related to endometrial receptivity. WHAT IS KNOWN ALREADY: Controversy exists around COCP pretreatment for IVF cycle programming as some authors claim that it might be detrimental to the live birth rate. Microarray technology applied to the study of tissue gene expression has previously revealed the behavior of genes related to endometrial receptivity under different conditions. STUDY DESIGN SIZE AND DURATION: Proof-of-concept study of 10 young h…

Adultmedicine.medical_specialtyAdolescentmedicine.medical_treatmentPopulationUterusGene ExpressionEndometriumEndometriumYoung AdultOvulation InductionmedicineHumansEmbryo ImplantationeducationMenstrual CycleGynecologyeducation.field_of_studyPregnancymedicine.diagnostic_testGenitourinary systembusiness.industryRehabilitationObstetrics and Gynecologymedicine.diseaseContraceptives Oral Combinedmedicine.anatomical_structureReproductive MedicineFemaleCombined oral contraceptive pillLive birthbusinessEndometrial biopsyHuman reproduction (Oxford, England)
researchProduct

Live birth after embryo transfer in an unresponsive thin endometrium.

2014

A healthy term livebirth in a 35-year-old woman with ovarian failure, hypoplastic uterus and atrophic endometrium after cancer treatment with chemotherapy and radiotherapy was achieved by ovum donation. The detection of a receptive endometrium using a new diagnostic tool of endometrial receptivity encouraged the medical team to carry on with this poor prognosis case. To the best of our knowledge, here we report the thinnest endometrium to date in which a healthy, full term live birth has been described in assisted conception.

Adultmedicine.medical_specialtyPoor prognosisTerm BirthEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEndometriumAtrophic endometriumEndometriumEndocrinologyPregnancymedicineHumansEmbryo ImplantationFull TermGynecologyOocyte Donationurogenital systemObstetricsbusiness.industryGene Expression ProfilingInfant NewbornObstetrics and GynecologyEmbryo Transferfemale genital diseases and pregnancy complicationsEmbryo transferRadiation therapymedicine.anatomical_structureFemaleEndometrial receptivityLive birthbusinessGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective…

2017

Objective To compare the efficacy of oocyte vitrification (OV) with that of ovarian cortex cryopreservation and transplantation (OCT) in women undergoing gonadotoxic treatments. Design Prospective observational cohort study. Setting Not applicable. Patient(s) Candidates for chemo-/radiotherapy who joined our fertility preservation (FP) program were included in this study between 2005 and 2015. One cohort included 1,024 patients undergoing OV; the other cohort included 800 patients undergoing OCT. Intervention(s) OV using the cryotop device and OCT using a slow freezing protocol. Main Outcome Measure(s) Live-birth rate (LBR) and clinical pregnancy rate (CPR). Result(s) Basal antimullerian ho…

Adultmedicine.medical_specialtyPregnancy RateAntineoplastic AgentsYoung Adult03 medical and health sciences0302 clinical medicinePregnancymedicineHumansProspective StudiesFertility preservationOvarian reserveProspective cohort studyCryopreservationGynecologyPregnancy030219 obstetrics & reproductive medicineRadiotherapybusiness.industryOvaryFertility PreservationObstetrics and Gynecologymedicine.diseaseVitrificationTransplantationFertilityTreatment OutcomeReproductive Medicine030220 oncology & carcinogenesisRelative riskCohortOocytesFemalebusinessInfertility FemaleLive BirthCohort studyFertility and Sterility
researchProduct

Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors

2013

Objective To analyze the reproductive outcome of recipients of donated ova according to their body mass index (BMI). Design Twelve-year retrospective cohort analysis. Setting Fertility clinics. Patient(s) 9,587 first cycles of ovum donation with ova from normoweight donors. Intervention(s) Recipients divided according to their BMI to analyze IVF laboratory and outcome parameters: lean with BMI 2 (n = 1,458; 15.2%); normoweight with BMI 20–24.9 kg/m 2 (n = 5,706; 59.5%), overweight with BMI 25–29.9 kg/m 2 (n = 1,770; 18.5%), and obese with BMI ≥30 kg/m 2 (n = 653; 6.8%). Main Outcome Measure(s) Implantation, biochemical and clinical pregnancy, miscarriage, and live-birth rates. Result(s) In …

Adultmedicine.medical_specialtyPregnancy RateFertilization in VitroOverweightBody Mass IndexMiscarriagePregnancyRisk FactorsOdds RatioHumansMedicineEmbryo ImplantationObesityTwin PregnancyRetrospective StudiesGynecologyAnalysis of VariancePregnancyChi-Square DistributionOocyte Donationbusiness.industryObstetricsBody WeightUterusnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseaseObesityTissue DonorsAbortion SpontaneousPregnancy rateLogistic ModelsTreatment OutcomeReproductive MedicineSpainPregnancy TwinFemalemedicine.symptomLive birthbusinessInfertility FemaleLive BirthBody mass indexFertility and Sterility
researchProduct

How to demonstrate that eSET does not compromise the likelihood of having a baby?

2009

BACKGROUND: In several randomized studies, elective single embryo transfer (eSET) has proven its effectiveness in reducing twin pregnancy rates while obtaining acceptable overall pregnancy rates. However, there is no outcome measurement consensus to evaluate the effectiveness of eSET versus double-embryo transfer (DET). METHODS: This study evaluated whether or not adopting an eSET strategy instead of a DET strategy lowers the probability of having at least one live-born infant in good prognosis couples. Seven hundred and twenty-six couples were divided into two groups. The retrospective arm of the study was undertaken on the first group of couples (n = 483, DET group) and the prospective ar…

Adultmedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentStatistics as TopicSingle Embryo TransferMultiple Birth OffspringIntracytoplasmic sperm injectionClinical ProtocolsPregnancyOutcome Assessment Health CaremedicineSingle Embryo TransferHumansPregnancyObstetricsbusiness.industryRehabilitationObstetrics and Gynecologymedicine.diseaseEmbryo TransferOutcome (probability)Embryo transferPregnancy rateReproductive MedicineInfertilityObservational studyFemalebusinessLive birthHuman reproduction (Oxford, England)
researchProduct

Elective single versus double embryo transfer: live birth outcome and patient acceptance in a prospective randomised trial

2013

The purpose of this study was to determine which strategy of embryo transfer has a better trade-off in live birth delivery rate versus multiple pregnancy considering patient acceptance: elective single embryo transfer (eSET) or elective double embryo transfer (eDET). In all, 199 women <38 years of age undergoing their first IVF treatment in a private centre were included in a prospective open-label randomised controlled trial. Patients were randomised into four groups: (1) eSET on Day 3; (2) eSET on Day 5; (3) eDET on Day 3; and (4) eDET on Day 5. Per patient, main analysis included acceptance of assigned group, as well as multiple and live birth delivery rates of the fresh cycle. Second…

Adultmedicine.medical_specialtyPregnancy Ratemultiple birth ratemultiple pregnancyFertilization in VitroReproductive technologyBiologyBirth ratelaw.inventionEndocrinologyRandomized controlled trialPregnancylawSingle Embryo TransferGeneticsmedicineHumansProspective Studiesdelivery rateBirth RateMolecular BiologyPregnancyObstetricsPregnancy OutcomeEmbryo culturePatient Acceptance of Health CareEmbryo Transfermedicine.diseaseEmbryo transferPregnancy rateTreatment OutcomeReproductive MedicineFemaleAnimal Science and ZoologyPregnancy MultipleLive birthLive BirthMaternal AgeDevelopmental BiologyBiotechnologyReproduction, Fertility and Development
researchProduct

Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births.

2011

Abstract Introduction. Premature ovarian failure (POF) can occur naturally at an early age or be due to iatrogenic agents. Indeed, ovaries are very sensitive to cytotoxic treatment, especially to radiation and alkylating agents. Methods. Several options are currently available to preserve fertility in cancer patients and allow them to conceive when they have overcome their disease: embryo cryopreservation, oocyte cryopreservation, and ovarian tissue cryopreservation. Cryopreservation of ovarian tissue is the only option available for pre-pubertal girls and women who cannot delay the start of chemotherapy. Findings. Since the first live birth after autotransplantation of cryopreserved ovaria…

Adultmedicine.medical_specialtyendocrine system diseasesOvarian Cortexmedicine.medical_treatmentAntineoplastic AgentsBiologyPrimary Ovarian InsufficiencyTransplantation AutologousCryopreservationYoung AdultEmbryo cryopreservationPregnancyNeoplasmsmedicineHumansOvarian tissue cryopreservationPremature ovarian failureCancerGynecologyCryopreservationTransplantationOvarian cryopreservationOvaryPregnancy OutcomeGeneral MedicineOocyte cryopreservationmedicine.diseasePrognosisfemale genital diseases and pregnancy complicationsAutotransplantationPremature ovarian failureInsufficiencyTransplantationFemaleLive BirthAnnals of medicine
researchProduct

Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

2017

Background & Aims Premenopausal women who are HCV positive (HCV+) have failing ovarian function, which is likely to impact their fertility. Thus, we investigated the reproductive history, risk of infertility, and pregnancy outcomes in women of childbearing age who were HCV+. Methods Three different groups were studied: (1) Clinical cohort: 100 women who were HCV+ and also had chronic liver disease (CLD), age matched with 50 women who were HBV+ with CLD and with 100 healthy women; all women were consecutively observed in three gastroenterology units in hospitals in Italy; (2) 1,998 women who were HCV+ and enrolled in the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)…

Anti-Mullerian hormone; Antiviral therapy; HBV; HCV; Sustained viral response; HepatologyInfertilitymedicine.medical_specialtySustained viral responsemedia_common.quotation_subjectFertilityAnti-Müllerian hormoneAntiviral therapyMiscarriage03 medical and health sciences0302 clinical medicineHBVMedicineProspective cohort studymedia_commonGynecologyAnti-Müllerian hormone Antiviral therapy HBV HCV Sustained viral response030219 obstetrics & reproductive medicineHepatologybusiness.industryObstetricsAnti-Müllerian hormone; Antiviral therapy; HBV; HCV; Sustained viral responseAnti-Mullerian hormonemedicine.diseaseAnti-Müllerian hormoneGestational diabetesCohortHCV030211 gastroenterology & hepatologyAnti-Müllerian hormone; Antiviral therapy; HBV; HCV; Sustained viral response; HepatologybusinessLive birthCell aging
researchProduct